Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
60000 participants
OBSERVATIONAL
2025-01-15
2030-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA
NCT06748261
Deep Learning Algorithm for Detecting Obstructive Coronary Artery Disease Using Fundus Photographs
NCT06102226
Diagnosis of Structural Heart Disease Using MCG
NCT06315998
Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT
NCT06589843
Development and Validation of a Cardiac Magnetic Resonance-Based Multimodal Deep Learning Model for Long-Term Outcome Prediction in ST-Segment Elevation Myocardial Infarction
NCT07277400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will enroll subjects with CHD, and the enrollment will be divided into two phases.
Phase 1: Previous data of chest X-ray in patients with CHD. A minimum of 5000 patients is reached.
Phase 2: Prospective inclusion of general patients with chest X-ray. A minimum of 50000 patients is reached.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Previous data of chest X-ray in patients with CHD
Phase 1: Previous data of chest X-ray in patients with CHD. A minimum of 5000 patients is reached.
surgical or interventional validation
surgical or interventional validation
Prospective inclusion of general patients with chest X-ray
Prospective inclusion of general patients with chest X-ray. A minimum of 50000 patients is reached.
surgical or interventional validation
surgical or interventional validation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
surgical or interventional validation
surgical or interventional validation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Chest X-ray of patients with VSD;
3. Chest X-ray of patients with PDA;
4. Chest X-ray of patients with PFO;
5. Chest X-ray of patients with PS;
6. Chest X-ray of patients with TOF/PAA;
7. Chest X-ray of patients with MS;
8. Chest X-ray of patients with other heart diseases;
Exclusion Criteria
2. Serious Scoliosis;
3. Pulmonary inflammation or consolidation
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Anzhen Hospital
OTHER
Nanjing Medical University
OTHER
Shanghai Jiao Tong University School of Medicine
OTHER
Capital Medical University
OTHER
Sichuan University
OTHER
Kunming Medical University
OTHER
Anhui Medical University
OTHER
Shandong University
OTHER
Zhejiang University
OTHER
Peking Union Medical College
OTHER
Harbin Medical University
OTHER
Xi'an Jiaotong University
OTHER
Huazhong University of Science and Technology
OTHER
Guangdong Provincial People's Hospital
OTHER
Wuhan University
OTHER
Central South University
OTHER
University of Chinese Academy of Sciences
UNKNOWN
The First Hospital of Hebei Medical University
OTHER
Handan First Hospital
OTHER
Second Affiliated Hospital of Wenzhou Medical University
OTHER
Anyang Maternal and Child Health Care Center
UNKNOWN
Wenzhou Medical University
OTHER
Guangxi Medical University
OTHER
Xinjiang Medical University
OTHER
Chongqing General Hospital
OTHER
Tibet Autonomous Region People's Hospital
OTHER
The Affiliated Hospital of Zunyi Medical College
UNKNOWN
Second Affiliated Hospital of Nanchang University
OTHER
Second Xiangya Hospital of Central South University
OTHER
Second Hospital of Shanxi Medical University
OTHER
Handan Central Hospital
OTHER
Affiliated First Hospital of Ningxia Medical University
UNKNOWN
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
Xijing Hospital
OTHER
Inner Mongolia People's Hospital
OTHER
Qinghai province cardiovascular and cerebrovascular disease specialist hospital
UNKNOWN
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
China Medical University, China
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Qilu Hospital of Shandong University
OTHER
Tianjin Medical University General Hospital
OTHER
Hainan General Hospital
OTHER
Fujian Medical University
OTHER
Lanzhou University Second Hospital
OTHER
Second Hospital of Jilin University
OTHER
Zunyi Medical College
OTHER
Ningxia Medical University
OTHER
LanZhou University
OTHER
Jilin University
OTHER
West China Hospital
OTHER
Peking University
OTHER
Fudan University
OTHER
Ruijin Hospital
OTHER
Zhengzhou University
OTHER
China National Center for Cardiovascular Diseases
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shihua Zhao, MD and PhD
Role: STUDY_CHAIR
Fuwai Hospital, Beijing, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fuwai hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021YFF0501400
Identifier Type: OTHER
Identifier Source: secondary_id
2020-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.